A systematic review of the definitions, determinants, and clinical outcomes of antimicrobial de-escalation in the intensive care unit.
Open accessThe DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
Antimicrobial de-escalation (ADE) is a strategy to reduce the spectrum of antimicrobials and aims to prevent the emergence of bacterial resistance. We present a systematic review describing the definitions, determinants and outcomes associated with ADE. We included 2 randomized controlled trials and 12 cohort studies. There was considerable variability in the definition of ADE. It was more frequently performed in patients with broad-spectrum and/or appropriate antimicrobial therapy (P= .05 to .002), when more agents were used (P= .002), and in the absence of multidrug-resistant pathogens (P< .05). Where investigated, lower or improving severity scores were consistently associated with ADE (P= .04 to <.001). The pooled effect of ADE on mortality is protective (relative risk, 0.68; 95% confidence interval, .52-.88). Because the determinants of ADE are markers of clinical improvement and/or of lower risk of treatment failure this effect on mortality cannot be retained as evidence. None of the studies were designed to investigate the effect of ADE on antimicrobial resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most studies were observational, and there are concerns that de-escalation is used primarily in patients who are getting better, which is why the reported improved short-term mortality should be interpreted with caution [277, 279].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [279]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Measurement of Observer Agreement for Categorical Data
Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529310 · Cited by 81,148 · cited 1×
“Interrater agreement was calculated with free marginal κ statistics [8].”
MethodMeasuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · cited 1×
“Heterogeneity among studies was evaluated using the χ(2) test based on the Cochran Q statistic and quantified by the I(2) value [9].”
MethodMeta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 4×
“by DerSimonian and Laird [10], with the Egger test used for publication bias.”
MethodInfluentialCochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
(2014) · Medical Entomology and Zoology · Cited by 17,633
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,877
Dellit, T. H., Owens, R. C., McGowan, J. E., Gerding, D. N., Weinstein, R. A., Burke, J. P., Huskins, W. C., Paterson, D. L., Fishman, N. O., Carpenter, C. F., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510393 · Cited by 3,362
SINGH, N., ROGERS, P., ATWOOD, C. W., WAGENER, M. M., & YU, V. L. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.2.9909095 · Cited by 1,032 · cited 1×
“has been studied for shortening treatment [27], to date there is no evidence of this for ADE because none of the published studies was designed to evaluate this variable.”
BackgroundGarnacho-Montero, J., Gutiérrez-Pizarraya, A., Escoresca-Ortega, A., Corcia-Palomo, Y., Fernández-Delgado, E., Herrera-Melero, I., Ortiz-Leyba, C., & Márquez-Vácaro, J. A. (2014) · Intensive Care Medicine · doi:10.1007/s00134-013-3077-7 · Cited by 389 · cited 12×
“GarnachoMontero et al [22] 2014 No specific antimicrobials described Yes Yes No Yes Not ranked Once culture results were available”
BackgroundMethodResultInfluentialSelf-citation
Research works printed but not linked: 1
- Effective Practice and Organisation of Care (EPOC). EPOC resources for review authors. Oslo, Norway: Norwegian Knowledge Centre for the Health Services; 2014. Available at: http://epoc.cochrane.org/epoc-specific-resources-review-authors. Accessed 19 January 2016.
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Self-citationSurviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Self-citationTorres, A., Niederman, M. S., Chastre, J., Ewig, S., Fernandez-Vandellos, P., Hanberger, H., Kollef, M., Li Bassi, G., Luna, C. M., Martin-Loeches, I., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00582-2017 · Cited by 1,387
Self-citationBloodstream infections in critically ill patients: an expert statement
Timsit, J.-F., Ruppé, E., Barbier, F., Tabah, A., & Bassetti, M. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05950-6 · Cited by 448
Self-citationSartelli, M., Guirao, X., Hardcastle, T. C., Kluger, Y., Boermeester, M. A., Raşa, K., Ansaloni, L., Coccolini, F., Montravers, P., Abu-Zidan, F. M., et al. (2018) · World Journal of Emergency Surgery · doi:10.1186/s13017-018-0219-9 · Cited by 301
“cornerstones of antimicrobial stewardship programs [116].”
Rationalizing antimicrobial therapy in the ICU: a narrative review
Timsit, J.-F., Bassetti, M., Cremer, O., Daikos, G., de Waele, J., Kallil, A., Kipnis, E., Kollef, M., Laupland, K., Paiva, J.-A., et al. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05520-5 · Cited by 266
Self-citationUpdate of the treatment of nosocomial pneumonia in the ICU
Zaragoza, R., Vidal-Cortés, P., Aguilar, G., Borges, M., Diaz, E., Ferrer, R., Maseda, E., Nieto, M., Nuvials, F. X., Ramirez, P., et al. (2020) · Critical Care · doi:10.1186/s13054-020-03091-2 · Cited by 232
“Avoiding unnecessary treatments and reducing the spectrum and duration of treatment together with the reduction of adverse effects and/or possible interactions will be the ultimate aim [7, 8].”
BackgroundManagement of intra-abdominal infections: recommendations by the WSES 2016 consensus conference
Sartelli, M., Catena, F., Abu-Zidan, F. M., Ansaloni, L., Biffl, W. L., Boermeester, M. A., Ceresoli, M., Chiara, O., Coccolini, F., De Waele, J. J., et al. (2017) · World Journal of Emergency Surgery · doi:10.1186/s13017-017-0132-7 · Cited by 199
“However, the results direct expansion of antimicrobial regimen if it is too narrow and to perform a deescalation if it is too broad [128, 129], particularly in critically ill patients where de-escalation strategy is one of the cornerstones of antimicrobial stewardship programs [129].”
BackgroundTabah, A., Bassetti, M., Kollef, M. H., Zahar, J.-R., Paiva, J.-A., Timsit, J.-F., Roberts, J. A., Schouten, J., Giamarellou, H., Rello, J., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-019-05866-w · Cited by 191
Self-citationAntibiotic Use in the Intensive Care Unit: Optimization and De-Escalation
Campion, M., & Scully, G. (2018) · Journal of Intensive Care Medicine · doi:10.1177/0885066618762747 · Cited by 172
“Antimicrobial stewardship efforts have had varying success in the ICU.”
InfluentialTiming of antibiotic therapy in the ICU
Kollef, M. H., Shorr, A. F., Bassetti, M., Timsit, J.-F., Micek, S. T., Michelson, A. P., & Garnacho-Montero, J. (2021) · Critical Care · doi:10.1186/s13054-021-03787-z · Cited by 161
“To date, most studies have agreed on the fact that ADE is safe [42, 43].”
BackgroundSelf-citationSurviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026
Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Intensive Care Medicine · doi:10.1007/s00134-026-08361-1 · Cited by 141
Self-citationAn approach to antibiotic treatment in patients with sepsis
Martínez, M. L., Plata-Menchaca, E. P., Ruiz‐Rodríguez, J. C., & Ferrer, R. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd.2020.01.47 · Cited by 135
“There are several observational studies, and a meta-analysis including a high number of patients, that have found deescalation therapy to be safe practice associated with lower mortality rates in patients with severe sepsis and septic shock (95-98).”
Waele, J. J. D., Schouten, J. A., Beovič, B., Tabah, A., & Léone, M. (2020) · Intensive Care Medicine · doi:10.1007/s00134-019-05871-z · Cited by 129
Self-citationHanretty, A. M., & Gallagher, J. C. (2018) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2118 · Cited by 123
“However, the impact of deescalation on the emergence of resistance has not been well studied.(64) Increasing the focus on shortening durations of antibiotic therapy where evidence supports the practice can greatly decrease the overall impact on the human microbiota that selects for resistant organisms, allowing for re…”
BackgroundAntimicrobial Stewardship in the Hospital Setting: A Narrative Review
Giamarellou, H., Galani, L., Karavasilis, T., Ioannidis, K., & Karaiskos, I. (2023) · Antibiotics · doi:10.3390/antibiotics12101557 · Cited by 118
Surviving Sepsis campaign: international guidelines for Management of Sepsis and Septic Shock 2026
Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Critical Care Medicine · doi:10.1097/ccm.0000000000007075 · Cited by 117
Self-citationDe Bus, L., Depuydt, P., Steen, J., Dhaese, S., De Smet, K., Tabah, A., Akova, M., Cotta, M. O., De Pascale, G., Dimopoulos, G., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06111-5 · Cited by 114
Self-citationHernández-Tejedor, A., Peñuelas, Ó., Sirgo, G., Llompart-Pou, J. A., Herrejon, E. P., Estella, Á., Cabanes, M. P. F., Alcalá-Llorente, M. A., Galleymore, P. R., Azuara, B. O., et al. (2017) · Medicina Intensiva · doi:10.1016/j.medin.2017.03.004 · Cited by 114
Paul, M., Dickstein, Y., & Raz‐Pasteur, A. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.05.023 · Cited by 104
Guidelines for Antibiotic Prescription in Intensive Care Unit
Guleria, R., Mohan, A., Kulkarni, A. P., Madan, K., & Hadda, V. (2019) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-23101 · Cited by 94
Woerther, P., Lepeule, R., Burdet, C., Decousser, J., Ruppé, É., & Barbier, F. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.08.026 · Cited by 92
Characteristics of Staphylococcus aureus Bacteraemia and Predictors of Early and Late Mortality
Bassetti, M., Peghin, M., Trecarichi, E. M., Carnelutti, A., Righi, E., Giacomo, P. D., Ansaldi, F., Trucchi, C., Alicino, C., Cauda, R., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170236 · Cited by 86
PASCALE, G. D., Posteraro, B., D’Arrigo, S., Spinazzola, G., Gaspari, R., Bello, G., Montini, L. M., Cutuli, S. L., Grieco, D. L., Gravio, V. D., et al. (2020) · Critical Care · doi:10.1186/s13054-020-03265-y · Cited by 85
Bus, L. D., Denys, W., Catteeuw, J., Gadeyne, B., Vermeulen, K., Boelens, J., Claeys, G., Waele, J. J. D., Decruyenaere, J. M. A., & Depuydt, P. O. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4301-z · Cited by 85
Hara, G. L., Kanj, S. S., Pagani, L., Abbo, L. M., Endimiani, A., Wertheim, H. F. L., Amábile-Cuevas, C. F., Tattevin, P., Mehtar, S., Cardoso, F. L., et al. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.06.015 · Cited by 82
When not to start antibiotics: avoiding antibiotic overuse in the intensive care unit
Denny, K. J., Wale, J. D., Laupland, K. B., Harris, P. N. A., & Lipman, J. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.07.007 · Cited by 81
Self-citationBassetti, M., Peghin, M., Carnelutti, A., Righi, E., Merelli, M., Ansaldi, F., Trucchi, C., Alicino, C., Sartor, A., Toniutto, P., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4717-0 · Cited by 78
A proposal for a comprehensive approach to infections across the surgical pathway
Sartelli, M., Pagani, L., Iannazzo, S., Moro, M. L., Viale, P., Pan, A., Ansaloni, L., Coccolini, F., D’Errico, M. M., Agreiter, I., et al. (2020) · World Journal of Emergency Surgery · doi:10.1186/s13017-020-00295-3 · Cited by 65
“Antibiotic deescalation has been associated with lower mortality rates in ICU patients and is now considered a key practice for antimicrobial stewardship purposes [75] .”
BackgroundIs de-escalation of antimicrobials effective? A systematic review and meta-analysis
Ohji, G., Doi, A., Yamamoto, S., & Iwata, K. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.06.002 · Cited by 64
“A recently published systematic review and meta-analysis combined studies on infections occurring in the ICU.40 Although the random-effects model of meta-analysis allows various types of study to be included, and this may produce statistically significant findings, the present authors considered it clinically importan…”
BackgroundAntimicrobial Treatment Duration in Sepsis and Serious Infections
Busch, L. M., & Kadri, S. S. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa247 · Cited by 63
“In order to evaluate the evidence behind this practice, Tabah et al published a systematic review and meta-analysis of antimicrobial de-escalation specifically in septic ICU patients [92].”
BackgroundHadi, H. A., Eltayeb, F., Balushi, S. A., Daghfal, J., Ahmed, F., & Mateus, C. (2024) · Antibiotics · doi:10.3390/antibiotics13030253 · Cited by 60
“…the picture is not fully clear, since there is a counterargument that restricting antimicrobials at critical care settings might be protective through limiting unfavorable adverse events or might be confounded by the plausible practice of reducing interventions in less critical patients [74].”
BackgroundResultMontravers, P., Augustin, P., Grall, N., Desmard, M., Allou, N., Marmuse, J.-P., & Guglielminotti, J. (2016) · Critical Care · doi:10.1186/s13054-016-1267-8 · Cited by 55
“However, although a recent analysis suggested that polymicrobial infection was a negative factor for de-escalation [20], we did not observe this trend in the patients in our present study.”
BackgroundResultInfluentialAntibiotic stewardship in community-acquired pneumonia
Viasus, D., Vecino-Moreno, M., de la Hoz, J. M., & Carratalà, J. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1274232 · Cited by 59
Bystander Selection for Antimicrobial Resistance: Implications for Patient Health
Morley, V. J., Woods, R. J., & Read, A. F. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2019.06.004 · Cited by 56
Carbapenem use in critically ill patients
Patrier, J., & Timsit, J. (2019) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000622 · Cited by 55
“There is no consensus definition of when and how to de-escalate [41,42].”
BackgroundSelf-citationGustinetti, G., Raiola, A. M., Varaldo, R., Galaverna, F., Gualandi, F., Bono, V. D., Bacigalupo, A. P., Angelucci, E., Viscoli, C., & Mikulska, M. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.03.018 · Cited by 53
Routsi, C., Gkoufa, A., Arvaniti, K., Kokkoris, S., Tourtoglou, A., Theodorou, V., Vemvetsou, A., Kassianidis, G., Amerikanou, A., Paramythiotou, E., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa375 · Cited by 46
Wang, S., Zhang, Y., Zhang, X., & Li, J. (2019) · World Journal of Urology · doi:10.1007/s00345-019-02772-0 · Cited by 52
López-Cortés, L. E., Delgado-Valverde, M., Moreno-Mellado, E., Goikoetxea Aguirre, J., Guio Carrión, L., Blanco Vidal, M. J., López Soria, L. M., Pérez-Rodríguez, M. T., Martínez Lamas, L., Arnaiz de las Revillas, F., et al. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00686-2 · Cited by 38
Antimicrobial Therapy and Antimicrobial Stewardship in Sepsis
Seok, H., Jeon, J. H., & Park, D. W. (2020) · Infection and Chemotherapy · doi:10.3947/ic.2020.52.1.19 · Cited by 51
“Although ADE was shown to be associated with lower mortality in meta-analyses [38, 39], this is due to the results of observational studies and implies bias.”
ResultS3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge – Update 2025
Brunkhorst, F. M., Adamzik, M., Axer, H., Bauer, M. W., Bode, C., Bone, H.-G., Brenner, T., Bucher, M., David, S., Dietrich, M., et al. (2025) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-025-01317-1 · Cited by 47
Waele, J. J. D., & Dhaese, S. A. M. (2019) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1568239 · Cited by 47
“Although arguably, antibiotic deescalation (ADE) may limit the use of these antibiotic empirical schemes [64], in many patients ADE is eventually not done because of various reasons – in a systematic review of the literature, ADE in critically ill patients was done in only around 50% of the patients [23].”
BackgroundChallenges and research priorities to progress the impact of antimicrobial stewardship
Bassetti, M., Giacobbe, D. R., Vena, A., & Brink, A. J. (2019) · Drugs in Context · doi:10.7573/dic.212600 · Cited by 45
Development of an Electronic Definition for De-escalation of Antibiotics in Hospitalized Patients
Moehring, R. W., Ashley, E. S. D., Davis, A. E., Dyer, A., Parish, A., Ren, X., Lokhnygina, Y. V., Hicks, L. A., Srinivasan, A., & Anderson, D. J. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa932 · Cited by 45
Piperacillin–tazobactam as alternative to carbapenems for ICU patients
Pilmis, B., Jullien, V., Tabah, A., Zahar, J., & Brun‐Buisson, C. (2017) · Annals of Intensive Care · doi:10.1186/s13613-017-0334-x · Cited by 44
“A recent systematic review, including two randomized controlled trials and 12 cohort studies, highlighted that the effects of ADE on antimicrobial resistance have not been properly studied [7].”
BackgroundSelf-citationThorndike, J., & Kollef, M. H. (2020) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000751 · Cited by 42
de Molina, F. J. G., Vidal, F. G., Estella, Á., Valdeolmillos, P. M., Ortega, J. F. F., López, J. C., Villares, P. V. P., Sanz, M. A. B., de Haro, C., Riera, J. A. S.-I., et al. (2018) · Medicina Intensiva · doi:10.1016/j.medin.2018.04.001 · Cited by 42
Efficacy and safety of antimicrobial de-escalation as a clinical strategy
Mathieu, C., Pastène, B., Cassir, N., Martín‐Loeches, I., & Léone, M. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1561275 · Cited by 41
“Intra-abdominal infections (IAIs) and polymicrobial infections are factors that have been found to be negatively associated with de-escalation [8].”
BackgroundMethodInfluentialDinh, A., Duran, C., Davido, B., Bouchand, F., Deconinck, L., Matt, M., Sénard, O., Guyot, C., Levasseur, A.-S., Attal, J., et al. (2017) · Journal of Hospital Infection · doi:10.1016/j.jhin.2017.07.005 · Cited by 40
Tabah, A., Lipman, J., Barbier, F., Buetti, N., Timsit, J., & on behalf of the ESCMID Study Group for Infections in Critically Ill Patients—ESGCIP (2022) · Antibiotics · doi:10.3390/antibiotics11030362 · Cited by 39
“Specific Pathogens While ADE and narrow-spectrum antibiotics can be easily recommended for susceptible micro-organisms, globally increasing antimicrobial resistance (AMR) has significantly complicated antibiotic management as detailed in the examples below.”
InfluentialSelf-citationOptimizing the Use of Antibiotic Agents in the Pediatric Intensive Care Unit: A Narrative Review
Willems, J., Hermans, E., Schelstraete, P., Depuydt, P. O., & Cock, P. A. J. G. D. (2020) · Pediatric Drugs · doi:10.1007/s40272-020-00426-y · Cited by 37
“No uniform definition of ADE is available [46].”
BackgroundMoniz, P., Coelho, L., & Póvoa, P. M. S. R. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01558-w · Cited by 38
Sieswerda, E., Bax, H. I., Hoogerwerf, J. J., de Boer, M. G. J., Boermeester, M. A., Bonten, M. J. M., Dekker, D., van Wijk, R. G., Juffermans, N. P., Kuindersma, M., et al. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07653-3 · Cited by 35
Self-citationKashiouris, M. G., Zemore, Z., Kimball, Z., Stefanou, C., Fowler, A. A., Fisher, B., de Wit, M., Pedram, S., & Sessler, C. N. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003921 · Cited by 35
“Antimicrobial stewardship can take many forms, with common aims being dose optimization, avoidance of redundancy, and inciting a de-escalation strategy which in itself may lead to a significant mortality reduction (36, 37).”
BackgroundOrtiz, F. J. G. D. M., Vidal, F. G., García, A., Valdeolmillos, P. M., Ortega, J. F. F., López, J. C., Villares, P. V. P., Sanz, M. A. B., de Haro, C., Riera, J. A. S.-I., et al. (2018) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2018.04.007 · Cited by 33
Trupka, T., Fisher, K., Micek, S. T., Juang, P., & Kollef, M. H. (2017) · Critical Care · doi:10.1186/s13054-017-1772-4 · Cited by 33
“Moreover, antibiotic de-escalation is accepted as a part of the global antimicrobial stewardship approach, inclusive of other elements such as the route and mode of antibiotic administration and the total duration of antimicrobial therapy [15].”
BackgroundShiraishi, C., Kato, H., Ogura, T., & Iwamoto, T. (2024) · Scientific Reports · doi:10.1038/s41598-024-69279-6 · Cited by 31
Antimicrobial De-Escalation in Critically Ill Patients
Tanzarella, E. S., Cutuli, S. L., Lombardi, G., Cammarota, F., Caroli, A., Franchini, E. O., Sancho, E., Grieco, D. L., Antonelli, M. M., & PASCALE, G. D. (2024) · Antibiotics · doi:10.3390/antibiotics13040375 · Cited by 32
“These results were in contrast with previous reports in which ADE ranged between 25% and 81% [9,11], possibly due to the inclusion of patients with lower illness severity compared to the DIANA study, different definitions, and timing of ADE.”
BackgroundResultInfluentialFocus on antimicrobial use in the era of increasing antimicrobial resistance in ICU
Bassetti, M., Poulakou, G., & Timsit, J. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4341-4 · Cited by 31
Self-citationBasic, Advanced, and Novel Metrics to Guide Antibiotic Use Assessments
Yarrington, M. E., & Moehring, R. W. (2019) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-019-00188-3 · Cited by 29
Garnacho‐Montero, J., & Amaya‐Villar, R. (2022) · Medicina Intensiva · doi:10.1016/j.medin.2021.12.002 · Cited by 29
Self-citationYamba, K., Chizimu, J. Y., Mudenda, S., Lukwesa, C., Chanda, R., Nakazwe, R., Simunyola, B., Shawa, M., Kalungia, A. C., Chanda, D. M., et al. (2024) · Journal of Hospital Infection · doi:10.1016/j.jhin.2024.03.014 · Cited by 28
Weiss, E., Zahar, J., Garrouste-Orgeas, M., Ruckly, S., Essaied, W. I., Schwebel, C., Timsit, J., & On behalf of the OUTCOMEREA Study Group (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4448-7 · Cited by 28
Self-citationYoshida, H., Motohashi, T., Bus, L. D., Waele, J. J. D., Takaba, A., Kuriyama, A., Kobayashi, A., Tanaka, C., Hashi, H., Hashimoto, H., et al. (2022) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-022-01146-3 · Cited by 26
“Various attempts have been made to reduce antimicrobial usage in ICUs, including using procalcitonin to initiate or discontinue use of antimicrobials [6, 7], interventions by antimicrobial stewardship teams [8, 9], and antimicrobial discontinuation strategies using scoring systems [10].”
BackgroundResultInfluentialHu, L., Yang, C., Huang, L., Cui, Y., Xu, D., Wu, C., & Tang, J. (2018) · Chinese Medical Journal · doi:10.4103/0366-6999.231529 · Cited by 26
“[11,17] Although a systemic review[18] showed that de‐escalation exerted a protective effect on mortality, the authors revealed that this effect might be attributed to clinical improvement or low risk of treatment failure, and thus, could not be retained as evidence.”
BackgroundBrinkmann, A., Röhr, A. C., Frey, O. R., Krüger, W. A., Brenner, T., Richter, D., Bodmann, K. ‐., Kresken, M., & Grabein, B. (2018) · Der Anaesthesist · doi:10.1007/s00101-018-0512-8 · Cited by 25
Gutiérrez-Pizarraya, A., Léone, M., Garnacho‐Montero, J., Martin, C., & Martín‐Loeches, I. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1293520 · Cited by 25
“study as the report focus on a particular microorganism family, and for a specific syndrome, in this case for enterobacteriae and bacteremia, respectively [22].”
BackgroundSelf-citationKhan, R. A., & Aziz, Z. (2018) · International Journal of Clinical Practice · doi:10.1111/ijcp.13245 · Cited by 25
Park, J., Lee, Y. J., Lee, J., Park, S. S., Cho, Y., Lee, S., Kim, Y. W., Han, S. K., & Yoo, C. (2017) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.346 · Cited by 24
“However, the efficacy of de-escalation strategies in improving individual patient outcomes remains controversial [30].”
BackgroundKhan, R. A., & Aziz, Z. (2017) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-017-0499-2 · Cited by 23
Carbapenem de-escalation as an antimicrobial stewardship strategy: a narrative review
Gardner, A., Nieberg, P., Sakoulas, G., & Wong‐Beringer, A. (2025) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaf022 · Cited by 22
Effective implementation of the Accelerate Pheno™ system for positive blood cultures
Humphries, R. M., & Martino, T. D. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky534 · Cited by 21
DiDiodato, G., & McAthur, L. (2017) · BMJ Open Quality · doi:10.1136/bmjoq-2017-000060 · Cited by 21
on behalf of The Nine-I study Group, Rello, J., Sarda, C., Mokart, D., Arvaniti, K., Akova, M., Tabah, A., & Azoulay, É. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03736-3 · Cited by 20
Self-citationGuidelines for Antibiotics Prescription in Critically Ill Patients
Chaudhry, D., Desai, M., Gupta, M., Mohan, A., Mehta, Y. B., Sengar, M., Govil, D., Hegde, A. V., Rungta, N., Mittal, S., et al. (2024) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24677 · Cited by 20
Unmet needs in the management of intra-abdominal infections
Montravers, P., Tashk, P., & Tran‐Dinh, A. (2017) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1372750 · Cited by 20
“Several definitions have been used to describe the de-escalation process, but the general purpose remains the same [70,71].”
BackgroundAbelenda-Alonso, G., Rombauts, A., Gudiol, C., García-Lerma, E., Pallarés, N., Ardanuy, C., Calatayud, L., Niubó, J., Tebé, C., & Carratalà, J. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.06.021 · Cited by 20
Guillamet, C. V., Burnham, J. P., & Kollef, M. H. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1693160 · Cited by 20
Vallicelli, C., Santandrea, G., Sartelli, M., Coccolini, F., Ansaloni, L., Agnoletti, V., Bravi, F., & Catena, F. (2022) · Antibiotics · doi:10.3390/antibiotics11111460 · Cited by 19
Esteve-Palau, E., Grau, S., Herrera, S., Sorlí, L., Montero, M., Segura, C., Durán, X., & Horcajada, J. P. (2018) · PubMed Central · Cited by 19
De-escalating Antibiotic Use in the Inpatient Setting: Strategies, Controversies, and Challenges
Markley, J. D., Bernard, S., Bearman, G. M., & Stevens, M. (2017) · Current Infectious Disease Reports · doi:10.1007/s11908-017-0575-8 · Cited by 19
ESTRATEGIAS PARA EL USO DE ANTIBIÓTICOS EN PACIENTES CRÍTICOS
Arancibia, J. M. (2019) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2019.03.001 · Cited by 18
Yamaguchi, R., Yamamoto, T., Okamoto, K., Tatsuno, K., Ikeda, M., Tanaka, T., Wakabayashi, Y., Sato, T., Okugawa, S., Moriya, K., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271812 · Cited by 17
“In this study, “de-escalation” was defined as ceasing anti-MRSA agents in the following two modes [10]: “discontinuation,” discontinuing unnecessary anti-MRSA agents (e.”
BackgroundAldardeer, N. F., Qushmaq, I. A., Alshehail, B. M., Ismail, N., Alhameed, A. F., Damfu, N., Musawa, M. A., Nadhreen, R., Kalkatawi, B. S., Saber, B., et al. (2023) · Journal of Epidemiology and Global Health · doi:10.1007/s44197-023-00124-1 · Cited by 17
Alanazi, A., Almuhaya, R. A., Almohaimeed, M., Alahmari, N., Abdulrahim, N., Basyouni, M. H., Althikrallah, F. M., Badwyi, J. A., Khallaf, A., Albalawi, K., et al. (2023) · Pharmacoepidemiology · doi:10.3390/pharma2040025 · Cited by 17
A Practical Approach to Clinical Antibiotic Stewardship in the ICU Patient with Severe Infection
Fierens, J., Depuydt, P. O., & Waele, J. J. D. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1693995 · Cited by 17
Léone, M., Roberts, J. A., Bassetti, M., Bouglé, A., Lavigne, J.-P., Legrand, M. M., Neely, M. N., Paiva, J.-A., Payen, D. M., Rello, J., et al. (2019) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2019.09.009 · Cited by 17
Self-citationAntibiotic treatment in patients with sepsis: a narrative review
Plata-Menchaca, E. P., Ferrer, R., Ruiz‐Rodríguez, J. C., Morais, R., & Póvoa, P. M. S. R. (2020) · Hospital Practice · doi:10.1080/21548331.2020.1791541 · Cited by 17
“In patients without ARDS, 1200 mg/day of linezolid was insufficient for the treatment of ICU patients, while a dose of 1400 mg/day administered q6 h or by continuous infusions provided an acceptable target achievement [144].”
BackgroundInfluentialAlbin, O. R., Saravolatz, L. I. I., Petrie, J. G., Henig, O., & Kaye, K. S. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac183 · Cited by 17
Waagsbø, B., Tranung, M., Damås, J. K., & Heggelund, L. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-02178-6 · Cited by 17
“De-escalation strategies are heavily recognized as a part of the global antimicrobial stewardship approach [16, 17].”
BackgroundThe role of antimicrobial therapy stewardship in intensive care service
Руднов, В. А., Колотова, Г. Б., Bagin, V. A., Nevskaya, N. N., Belsky, D. V., Ivanova, N. A., & Гайфутдинов, Е. А. (2018) · Clinical Microbiology and Antimicrobial Chemotherapy · doi:10.36488/cmac.2018.2.132-140 · Cited by 16
Umpleby, H., Dushianthan, A., Catton, T., & Saeed, K. B. A. (2022) · Journal of Emergency and Critical Care Medicine · doi:10.21037/jeccm-22-6 · Cited by 17
“The meta-analysis from Tabah et al. (19) included 14 studies that CI: 0.17–0.68 respectively).”
InfluentialBest practice: antibiotic decision-making in ICUs
Brink, A. J., & Richards, G. A. (2020) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000752 · Cited by 16
Optimized Treatment of Nosocomial Peritonitis
Waele, J. J. D., Coccolini, F., Lagunes, L., Maseda, E., Rausei, S., Perez, I. R., Θεοδωρακοπούλου, Μ., & Arvaniti, K. (2023) · Antibiotics · doi:10.3390/antibiotics12121711 · Cited by 15
“Regarding the duration of antibiotic treatment, the STOP-IT study in 2015 proposed short antibiotic courses in certain patient populations [81].”
Choosing wisely: what is the actual role of antimicrobial stewardship in Intensive Care Units?
Montrucchio, G. G., Sales, G., Corcione, S., Rosa, F. G. D., & Brazzi, L. (2019) · Minerva Anestesiologica · doi:10.23736/s0375-9393.18.12662-9 · Cited by 15
Garnacho‐Montero, J., & Amaya‐Villar, R. (2022) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2022.04.006 · Cited by 15
Self-citationHughes, J. S., Huo, X., Falk, L., Hurford, A., Lan, K., Coburn, B. A., Morris, A. M., & Wu, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171218 · Cited by 15
Chen, Y., Sun, A. Y.-E., Narain, K., Chang, W.-C., Yang, C., Chen, P., Jhou, H., Dai, M., Rastogi, N., & Lee, C. (2025) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01597-24 · Cited by 14
“However, Tabah et al. also pointed out the difficulty of truly identifying the reason for the mortality benefit without confounding factors (42).”
Bonvento, B., Rooney, J., Columb, M., McGrath, B. A., Bentley, A. M., & Felton, T. (2018) · Journal of the Intensive Care Society · doi:10.1177/1751143718811113 · Cited by 14
Metadata
- Authors
- Tabah, A., Cotta, M. O., Garnacho-Montero, J., Schouten, J., Roberts, J. A., Lipman, J., Tacey, M., Timsit, J.-F., Leone, M., Zahar, J. R., & De Waele, J. J.
- Affiliations
- Royal Brisbane and Women's Hospital (AU)
- The University of Queensland (AU)
- Canisius-Wilhelmina Ziekenhuis (NL)
- Queensland University of Technology (AU)
- The Royal Melbourne Hospital (AU)
- Centre Hospitalier Universitaire d'Angers (FR)
- Corresponding author
- Tabah, Alexis
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-12-23
- Volume
- 62
- Issue
- 8
- Pages
- 1009-1017
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2253853790
- Cited by
- 220
- References
- 29
- Citations by year
- 2026: 14 · 2025: 13 · 2024: 20 · 2023: 18 · 2022: 31 · 2021: 13 · 2020: 26 · 2019: 24 · 2018: 25 · 2017: 21 · 2016: 14 · 2015: 1
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- Locations
- Clinical Infectious Diseases (publishedVersion, other-oa)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, other-oa)
- Funders
- Pfizer
- AstraZeneca
- Gilead Sciences
- Fonds Wetenschappelijk Onderzoek
- Astellas Pharma
- Vlaamse regering
- European Society of Intensive Care Medicine
- Medical Research Council
- National Health and Medical Research Council (1099452, 1048652)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- antibiotic de-escalation, intensive care unit, antimicrobial resistance, mortality, broad-spectrum antimicrobial therapy, multidrug-resistant pathogens, severity scoring, clinical outcomes
- MeSH terms
- Anti-Bacterial Agents, Bacterial Infections, Clinical Trials as Topic, Cross Infection, Drug Resistance, Microbial, Humans, Intensive Care Units, Severity of Illness Index, Cohort Studies, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.